AERI
Aerie Pharmaceuticals
AERI
AERI
Delisted
AERI was delisted on the 18th of November, 2022.
148 hedge funds and large institutions have $552M invested in Aerie Pharmaceuticals in 2020 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 50 increasing their positions, 50 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
23% less capital invested
Capital invested by funds: $712M → $552M (-$160M)
27% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 22
Holders
148
Holding in Top 10
1
Calls
$1.26M
Puts
$627K
Top Buyers
| 1 | +$10.6M | |
| 2 | +$8.77M | |
| 3 | +$8.05M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$5.36M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
+$3.25M |
Top Sellers
| 1 | -$10.1M | |
| 2 | -$9.35M | |
| 3 | -$7.85M | |
| 4 |
Handelsbanken Fonder
Stockholm,
Sweden
|
-$6.5M |
| 5 |
LCS
Levin Capital Strategies
New York
|
-$4.71M |